The synthesis of four tetra-tacrine clusters where the tacrine binding units are attached to a central scaffold via linkers of variable lengths is described. The multivalent inhibition potencies for the tacrine clusters were investigated for the inhibition of acetylcholinesterase. Two of the tacrine clusters displayed a small but significant multivalent inhibition potency in which the binding affinity of each of the tacrine binding units increased up to 3.2 times when they are connected to the central scaffold.publishedVersio
A series of novel tacrine derivatives and tacrine–coumarin heterodimers were designed, synthesized, ...
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, ...
A novel series of tacrine-lophine hybrids was synthesized and tested for their ability to inhibit ac...
The synthesis of four tetra-tacrine clusters where the tacrine binding units are attached to a centr...
Tacrine (THA) is approved by the FDA for the palliative treatment of Alzheimer's disease, but its us...
Analogues of tacrine were synthesized and evaluated for acetylcholinesterase (AChE) and butyrylcholi...
Investigation of acetylcholinesterase (AChE) inhibition potency of some new Schiff base derivatives ...
Dimeric acetylcholinesterase (AChE) inhibitors containing a single 9-amino-1,2,3,4-tetrahydroacridin...
AbstractBackground: Methods for the rapid and efficient preparation of drug candidates through combi...
Three man synthetic routes to analogues of tacrine are described: reaction of anthranilonitriles wit...
The synthesis of highly potent and selective acetylcholinesterase inhibitors, tacrine analogues with...
Several novel analogues of tacrine have been synthesized and tested for their ability to inhibit ace...
Based upon synthetic and biochemical results, a novel and potent tacrine analogue and heterobivalent...
The review summarizes research into the highly relevant topics of cholinesterase and amyloid aggrega...
Tacrine (THA), as the first approved acetylcholinesterase (AChE) inhibitors for the treatment of Alz...
A series of novel tacrine derivatives and tacrine–coumarin heterodimers were designed, synthesized, ...
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, ...
A novel series of tacrine-lophine hybrids was synthesized and tested for their ability to inhibit ac...
The synthesis of four tetra-tacrine clusters where the tacrine binding units are attached to a centr...
Tacrine (THA) is approved by the FDA for the palliative treatment of Alzheimer's disease, but its us...
Analogues of tacrine were synthesized and evaluated for acetylcholinesterase (AChE) and butyrylcholi...
Investigation of acetylcholinesterase (AChE) inhibition potency of some new Schiff base derivatives ...
Dimeric acetylcholinesterase (AChE) inhibitors containing a single 9-amino-1,2,3,4-tetrahydroacridin...
AbstractBackground: Methods for the rapid and efficient preparation of drug candidates through combi...
Three man synthetic routes to analogues of tacrine are described: reaction of anthranilonitriles wit...
The synthesis of highly potent and selective acetylcholinesterase inhibitors, tacrine analogues with...
Several novel analogues of tacrine have been synthesized and tested for their ability to inhibit ace...
Based upon synthetic and biochemical results, a novel and potent tacrine analogue and heterobivalent...
The review summarizes research into the highly relevant topics of cholinesterase and amyloid aggrega...
Tacrine (THA), as the first approved acetylcholinesterase (AChE) inhibitors for the treatment of Alz...
A series of novel tacrine derivatives and tacrine–coumarin heterodimers were designed, synthesized, ...
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, ...
A novel series of tacrine-lophine hybrids was synthesized and tested for their ability to inhibit ac...